A detailed history of Hrt Financial LP transactions in Virios Therapeutics, Inc. stock. As of the latest transaction made, Hrt Financial LP holds 57,544 shares of VIRI stock, worth $255,495. This represents 0.0% of its overall portfolio holdings.

Number of Shares
57,544
Holding current value
$255,495
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$0.18 - $0.58 $10,357 - $33,375
57,544 New
57,544 $12,000

Others Institutions Holding VIRI

About Virios Therapeutics, Inc.


  • Ticker VIRI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 18,330,400
  • Market Cap $81.4M
  • Description
  • Virios Therapeutics, Inc., a development-stage biotechnology company, focuses on developing antiviral therapies to treat diseases associated with a viral triggered abnormal immune response. The company's lead development candidate is the IMC-1, a fixed dose combination of famciclovir and celecoxib to treat fibromyalgia. It is also developing IMC...
More about VIRI
Track This Portfolio

Track Hrt Financial LP Portfolio

Follow Hrt Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.